Ibrahim El-Haffaf
6PUBLICATIONS
1CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Jan 20, 2026
Population pharmacokinetic modeling of piperacillin in critically ill adult patients: consideration of sex-based differences during model development.Ibrahim El-Haffaf, David Williamson, Van Dong Nguyen
|Jan 19, 2024
Exposure levels and target attainment of piperacillin/tazobactam in adult patients admitted to the intensive care unit: a prospective observational study.Ibrahim El-Haffaf, Amélie Marsot, Djamila Hachemi
|Sep 15, 2023
Potential benefits of therapeutic drug monitoring for beta-lactam antibiotics in augmented renal clearance patients: a case report.Ibrahim El-Haffaf, Jean Laverdière, Martin Albert
|Nov 29, 2022
Impact of piperacillin unbound fraction variability on dosing recommendations in critically ill patients.Ibrahim El-Haffaf, Romain Guilhaumou, Lionel Velly
|Mar 28, 2022
Using a Validated Population Pharmacokinetic Model for Dosing Recommendations of Continuous Infusion Piperacillin for Critically Ill Adult Patients.Ibrahim El-Haffaf, Romain Guilhaumou, Lionel Velly
|Apr 20, 2021
Piperacillin-Tazobactam in Intensive Care Units: A Review of Population Pharmacokinetic Analyses.Ibrahim El-Haffaf, Jean-Alexandre Caissy, Amélie Marsot
Pageof 1
